Although numerous long noncoding RNAs (lncRNAs) have been identified, our understanding of their roles in mammalian physiology remains limited. Here we investigated the physiologic function of the conserved lncRNA Norad in vivo. Deletion of Norad in mice results in genomic instability and mitochondrial dysfunction, leading to a dramatic multi-system degenerative phenotype resembling premature aging. Loss of tissue homeostasis in Norad-deficient animals is attributable to augmented activity of PUMILIO proteins, which act as post-transcriptional repressors of target mRNAs to which they bind. Norad is the preferred RNA target of PUMILIO2 (PUM2) in mouse tissues and, upon loss of Norad, PUM2 hyperactively represses key genes required for mitosis and mitochondrial function. Remarkably, enforced Pum2 expression fully phenocopies Norad deletion, resulting in rapid-onset aging-associated phenotypes. These
INTRODUCTION
Long noncoding RNAs (lncRNAs) comprise a heterogeneous class of transcripts that are defined by a sequence length greater than 200 nucleotides and the lack of a translated open reading frame (ORF). lncRNAs have been proposed to perform a variety of cellular functions including regulation of gene expression in cis and trans, modulation of functions of RNAs and proteins to which they bind, and organization of nuclear architecture 1 . Although they have been estimated to number in the tens of thousands 2 , the biological significance of the vast majority of lncRNAs remains to be established. This is due, in part, to the generally low abundance and poor evolutionary conservation of most lncRNAs, which has limited our ability to interrogate their biochemical functions as well as their biologic roles in vivo using model organisms. Moreover, while genetic studies in mice have uncovered important functions for selected mammalian lncRNA loci in development and disease states 3, 4 , it has often been challenging to connect specific lncRNA-driven phenotypes to defined RNA-mediated functions. As a result, our broad understanding of how the molecular pathways controlled by lncRNAs impact development and physiology remains limited.
Noncoding RNA activated by DNA damage (NORAD) is a recently described lncRNA that is distinguished from the majority of transcripts in this class due to its high abundance in mammalian cells and strong evolutionary conservation across mammalian species 5, 6 . Studies in human cells have established that this RNA functions as a strong negative regulator of PUMILIO1 (PUM1) and PUMILIO2 (PUM2), RNA binding proteins (RBPs) that belong to the deeply conserved family of Pumilio and Fem3 binding factor (PUF) proteins. PUM1/2 bind specifically to the 8 nucleotide (nt) PUMILIO response element (PRE) (UGUANAUA), which is often located in the 3' UTR of mRNAs. Binding of PUM1/2 to these sites triggers accelerated deadenylation, reduced translation, and turnover of mRNA targets 7, 8 . With the capacity to bind a large fraction of PUM1/2 within the cell, NORAD limits the availability of these proteins to repress target mRNAs 5, 6 . Consequently, inactivation of NORAD results in PUMILIO hyperactivity with augmented repression of a program of target mRNAs that includes key regulators of mitosis, DNA repair, and DNA replication. Dysregulation of these genes results in dramatic genomic instability in NORAD-deficient cells 5 . In accordance with this model, PUM2
overexpression is sufficient to phenocopy, while PUM1/2 loss-of-function is sufficient to suppress, the NORAD knockout phenotype in human cells. Recent work has also identified an interaction between NORAD and RBMX 9 , an RNA binding protein that contributes to the DNA 5 expressed throughout the body, with highest abundance in brain ( Fig. 1b and Supplementary   Fig. 1b) , and are predominantly localized to the cytoplasm, as determined by cell fractionation studies in mouse embryonic fibroblasts (MEFs) ( Fig. 1c ) and human cell lines 5, 6 .
To investigate the function of the mouse Norad ortholog, clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9-mediated genome editing was employed to delete the lncRNA-encoding sequence from the mouse genome, yielding three independent knockout lines ( Fig. 1d, e and Supplementary Fig. 1c) . Importantly, expression of the neighboring genes Epb41l1 and Cnbd2 was unaffected in Norad -/brain and spleen (Supplementary Fig. 1d ), demonstrating that deletion of the Norad locus does not perturb local gene regulation.
Norad loss-of-function results in a degenerative phenotype resembling premature aging
Norad -/mice were viable, fertile, and born at the expected Mendelian frequency ( Supplementary Fig. 2a ). Early in life, Norad-deficient mice were indistinguishable from wildtype littermates, but by six months of age, the onset of a multi-system degenerative phenotype resembling premature aging became apparent, with approximately 50% of the mice developing severe manifestations by one year of age ( Fig. 2a, b) . This phenotype was characterized by accelerated alopecia and graying of fur in male Norad -/mice ( Fig. 2a and Supplementary Fig.   2b ), while both male and female Norad -/mice displayed pronounced kyphosis ( Fig. 2b and   Supplementary Fig. 2c ). Increased kyphosis was also evident in Norad +/animals, indicating a dose-dependent effect of Norad loss of function. Although body weight was comparable between cohorts of Norad +/+ , Norad +/-, and Norad -/mice at one year of age ( Supplementary   Fig. 2d ), mice that developed outward features of aging such as kyphosis also exhibited significant weight loss accompanied by loss of total body fat and subcutaneous fat ( Fig. 2c-e ).
Abnormalities were also apparent in Norad-deficient skeletal muscle, with marked switching of fast twitch glycolytic (FTG) fibers to slow twitch oxidative (STO) fibers (Fig. 2f) , a phenomenon associated with normal muscle aging 13 . In addition, Norad -/mice showed accelerated onset of aging-associated pathologies within the central nervous system (CNS) [14] [15] [16] , including condensed neuronal cell bodies and an accumulation of lipofuscin and vacuoles within spinal motor neurons ( Fig. 2g and Supplementary Fig. 2e ). Similar pathologies were evident in neurons in the dorsal root ganglia, brain stem, and cerebellum (data not shown). These changes were accompanied by an overall reduction in neuronal density in the spinal cord ( Supplementary   Fig. 2f ). Finally, Norad -/mice showed decreased overall survival over a two-year interval ( Fig.   6 2h). These findings demonstrate that Norad is essential to suppress widespread agingassociated degenerative phenotypes in mice.
PUMILIO hyperactivity in Norad-deficient mice
Previous work established that NORAD is the preferred binding partner of PUM2 in human cells 5 . NORAD knockout or knockdown triggers PUMILIO hyperactivity and a consequent loss of genomic stability due to excessive PUMILIO-mediated repression of a set of target mRNAs that are critical for normal mitosis 5, 6 . Given the prior demonstration that genomic instability in mice causes aging-associated phenotypes 17, 18 , the regulation of PUMILIO activity by this lncRNA, and the resulting effects of PUMILIO hyperactivity, could potentially underlie the phenotype of Norad-deficient animals.
To assess whether Norad regulates PUMILIO activity in mice, we performed enhanced UV crosslinking immunoprecipitation coupled with high-throughput sequencing (eCLIP) 19 to assess the transcriptome-wide interactions of PUM2 with target RNAs in Norad +/+ and Norad -/mice (Supplementary Table 1 ). Brain was chosen for these experiments because Norad shows the highest expression in this tissue ( Fig. 1b and Supplementary Fig. 1b) , pathologic changes are present in the CNS of Norad -/mice ( Fig. 2g and Supplementary Fig. 2e, f) , and mammalian PUMILIO proteins have been implicated in various neuronal functions 10, 11, [20] [21] [22] [23] [24] .
Like human NORAD, the mouse transcript is highly enriched for PREs, harboring 11 perfect matches to the canonical PRE consensus and an additional 3 PREs conforming to a slightly relaxed consensus sequence (UGUANAUN) (Fig. 3a) . Accordingly, robust binding of PUM2 to Norad was detectable by eCLIP, with the majority of binding occurring in the vicinity of PRE sequences. Strikingly, Norad was by far the most highly bound PUM2 target in the transcriptome (Fig. 3b) , exhibiting at least 1000 times greater CLIP signal than 95% of all PUM2-bound mRNAs. Thus, as observed in human cell lines, but to a much greater extent in vivo, Norad is the preferred RNA target of PUM2 in mouse brain.
We next examined the transcriptome-wide interactions of PUM2 with target mRNAs. Notably, the relaxed PRE consensus was the most enriched sequence motif detected in PUM2-bound mRNA 3' UTRs, supporting the reliability of this eCLIP dataset ( Fig. 3c) . Moreover, PUM2 target occupancy was significantly increased and expression of PUM2 CLIP targets was significantly 7 decreased in Norad -/brain, consistent with PUMILIO hyperactivity (Fig. 3d, e ). Augmented repression of PUM2 CLIP targets was even more apparent when specifically examining targets whose PUM2 binding was measurably increased in Norad -/brains ( Fig. 3f) . Overall, these data strongly support a conserved function for Norad as a negative regulator of PUMILIO activity in vivo.
Norad deficiency leads to genomic instability
To assess whether Norad loss of function results in genomic instability, fluorescence in situ hybridization (FISH) was used to quantify the number of marker chromosomes in primary hematopoietic cells, a representative mitotic tissue. This analysis revealed a significant increase in aneuploid lymphocytes and splenocytes in 3-month and 12-month old Norad -/mice ( Fig. 4a) .
To directly determine whether loss of Norad results in mitotic abnormalities, murine embryonic fibroblasts (MEFs) were examined using DNA FISH and live cell imaging. In contrast to lymphocytes or splenocytes, we observed a high rate of polyploidization in all MEF lines tested, as previously reported 25 ( Supplementary Fig. 3a, b) . We therefore excluded tetraploid and octaploid cells from those scored as aneuploid (higher ploidy was rarely observed). Despite applying these stringent criteria, we detected a significant increase in aneuploidy in Norad -/-MEFs ( Supplementary Fig. 3a ). Moreover, time lapse microscopy revealed an increased occurrence of anaphase bridges and lagging chromosomes as Norad -/-MEFs underwent mitosis ( Fig. 4b) . Consistent with these findings and our previous observations in NORADdeficient human cell lines 5 , RNA-seq revealed significant repression of genes involved in the cell cycle, mitosis, DNA replication, and DNA repair in Norad -/spleens ( Fig. 4c, d) . These results establish a conserved, essential role for the Norad-PUMILIO axis in the maintenance of genomic stability in humans and mice.
Loss of Norad results in mitochondrial dysfunction
Phenotypic analyses of Norad-deficient mice unexpectedly revealed that in addition to genomic instability, widespread mitochondrial dysfunction was evident in knockout tissues. Overt mitochondrial abnormalities were observed in skeletal muscle of 12-month-old Norad -/mice, including large accumulations of subsarcolemmal mitochondria ( Fig. 5a,b ) accompanied by a significant increase in mitochondrial DNA (mtDNA) content ( Supplementary Fig. 4a ).
Ultrastructurally, these mitochondria appeared irregular in shape and enlarged, with loss of cristae ( Fig. 5b) . Similarly irregular and enlarged mitochondria were observed in spinal neurons 8 of Norad -/mice ( Fig. 5c ). These structural abnormalities were accompanied by evidence of reduced mitochondrial function, such as decreased cytochrome c oxidase (COX; also known as Complex IV of the electron transport chain) activity in spinal neurons ( Fig. 5d) . Additionally, rare COX-negative fibers were observed in Norad-deficient but not wild-type skeletal muscle ( Supplementary Fig. 4b) . These findings were noteworthy given the extensive evidence linking a decrease in mitochondrial function to aging-associated phenotypes 26 and the previous demonstration that mice lacking proofreading activity of the mtDNA polymerase, which consequently accumulate mtDNA mutations and deletions, exhibit a premature aging phenotype with many similarities to that seen in Norad -/mice 27 .
A major consequence of mitochondrial dysfunction that is believed to play a role in cellular damage and aging is the accumulation of reactive oxygen species (ROS) 28,29 . Indeed, brain and spinal cord of Norad -/mice show evidence of oxidative damage, including elevated levels of 3nitrotyrosine (3-NT), 4-hydroxynonenal (4-HNE), and 8-hydroxy-2'-deoxyguanosine/8hydroxyguanosine (8-OHdG/8-OHG), markers of protein, lipid, and nucleic acid oxidation, respectively ( Fig. 5e and Supplementary Fig. 4c ).
To directly assess mitochondrial function in Norad-deficient cells, respiration rates were analyzed in pairs of littermate-matched Norad +/+ and Norad -/-MEFs. Basal and maximal respiration was significantly reduced in Norad -/cells ( Fig. 5f) , accompanied by a decrease in mitochondrial membrane potential (MMP) and an increase in ROS production ( Fig. 5g) .
Respiration was also examined in human NORAD -/-HCT116 cells 5 . Unlike MEFs, HCT116 cells lacking NORAD exhibited a significant increase in mitochondrial content (Supplementary Fig.   5a -c). Nevertheless, when normalized to mtDNA copy number, a similar reduction in respiration and increase in ROS was detectable in these cells ( Supplementary Fig. 5d, e) . These results document a previously unrecognized requirement for Norad in the maintenance of mitochondrial homeostasis in mammalian cells and tissues.
To investigate the mechanism through which Norad loss-of-function leads to mitochondrial dysfunction, we examined RNA-seq data from Norad +/+ and Norad -/brain and spleen using Gene Set Enrichment Analysis (GSEA) 30 . Genes associated with mitochondria-related gene ontology (GO) terms, such as mitochondrial protein complex, electron transport chain, and oxidative phosphorylation, were significantly repressed in Norad-deficient tissues ( Supplementary Fig. 6a ). Remarkably, identical gene sets were repressed in human NORAD -/-HCT116 cells. We further identified a set of PUM2 brain CLIP targets within these gene sets that are known to perform important functions in mitochondrial biogenesis and homeostasis, mitochondrial transport, oxidative phosphorylation, metabolism, and ROS detoxification ( Fig.   5h ). Downregulation of a representative set of these genes was validated by qRT-PCR in Norad -/brain, spleen, and multiple independent MEF lines ( Fig. 5i and Supplementary Fig.   6b ). These data are consistent with a model in which PUMILIO hyperactivity in Norad-deficient cells and tissues leads to coordinated downregulation of a broad set of target genes that are critical for normal mitochondrial function.
Enforced PUM2 expression phenocopies Norad loss of function
While widespread genomic instability and mitochondrial dysfunction would be predicted to result in the premature aging-like phenotype displayed by Norad -/mice, it remained to be demonstrated whether PUMILIO hyperactivity alone could account for the full spectrum of observed phenotypes. To address this question, transgenic mice with doxycycline (dox)inducible expression of FLAG-tagged PUM2 were generated and crossed to mice harboring a ubiquitously-expressed reverse tetracycline-controlled transactivator 3 transgene (CAG-rtTA3) 31 ( Fig. 6a) . Administration of dox induced broad transgene expression in Pum2; rtTA3 double transgenic mice, as documented by FLAG immunohistochemistry (IHC) (Supplementary Fig.   7a ). Surprisingly, total levels of PUM2 protein were not increased at the bulk tissue level ( Supplementary Fig. 7b ), although this finding is consistent with the known negative feedback of PUM1 and PUM2 on their own transcripts 32-34 . Thus, these transgenic mice represent a model of deregulated, but not overtly overexpressed, PUM2. Because CAG-rtTA3 does not efficiently drive transgene expression in the CNS 31 , we focused our phenotypic studies of Pum2; rtTA3 double transgenic mice on peripheral tissues.
Administration of dox to young (8-14 week old) Pum2; rtTA3 double transgenic mice derived from two independent founders, but not to Pum2 or rtTA3 single transgenic controls, resulted in a striking phenotype within two months that closely resembled the appearance of Norad -/mice at one year of age. Dox-treated Pum2; rtTA3 mice developed rapidly progressing kyphosis, alopecia, graying of fur, and loss of body fat (Fig. 6b, c and Supplementary Fig. 7c ). These phenotypes were accompanied by increased aneuploidy in splenocytes ( Fig. 6d ) and the accumulation of subsarcolemmal, irregularly shaped mitochondria lacking normal cristae in skeletal muscle ( Fig. 6e, f) . Further demonstrating mitochondrial abnormalities, a global reduction in COX activity was observed in Pum2; rtTA3 skeletal muscle ( Fig. 6g and Supplementary Fig. 7d ) together with scattered necrotic and regenerating fibers ( Fig. 6h and Supplementary Fig. 7e ).
Lastly, we directly assessed whether enforced PUM2 expression impairs mitochondrial function in MEFs and human cell lines. Transient expression of FLAG-PUM2 in MEFs or stable expression of either PUM1 or PUM2 in HCT116 significantly impaired respiration ( Fig. 6i and Supplementary Fig. 7f, 8a-c) . Overall, these data provide compelling evidence that PUMILIO hyperactivity in Norad-deficient animals results in genomic instability, mitochondrial dysfunction, and ultimately a multi-system degenerative phenotype resembling premature aging. showed that slightly reduced PUM1 dosage causes neurodegeneration in human and mouse brain 10, 11 . Human subjects carrying heterozygous PUM1 deletions or missense mutations develop a neurodevelopmental disorder referred to as PUM1-associated developmental disability, ataxia, and seizure (PADDAS), associated with a ~50% reduction in PUM1 protein, or a later onset variant known as PUM1-related cerebellar ataxia (PRCA), associated with only a ~25% lowering of PUM1 levels 10 . Taken together with our findings from this study, in which we examined for the first time the effects of mammalian PUMILIO hyperactivity in vivo, we can conclude that PUMILIO activity must be maintained within a very narrow range in order to prevent widespread deleterious consequences. In light of these findings, we propose that one major function of Norad is to buffer PUMILIO activity such that it stays within this critical range.
DISCUSSION
This model posits the existence of Norad-bound and free PUMILIO pools which are exchangeable and in equilibrium, ensuring a consistent amount of available PUMILIO for target mRNA engagement and preventing fluctuations in PUMILIO expression from manifesting in altered target repression. Indeed, an RNA such as Norad represents an ideal molecule to serve as a buffer of this type, as it is able to efficiently regulate the activity of a pre-existing pool of PUMILIO at the level of target engagement.
In addition to providing a buffering function, it is likely that Norad is also utilized for dynamic regulation of PUMILIO activity under selected conditions. In particular, this lncRNA is known to be induced by a variety of cellular stressors, including DNA damage 5 and hypoxia 36 , which would be expected to result in de-repression of PUMILIO targets following these stimuli.
Although the functional consequences of modulating PUMILIO-mediated gene regulation under these conditions is not yet understood, continued investigation of the signaling inputs that control this system and the resulting effects on PUMILIO-regulated gene networks will be important to further elucidate the roles of this newly-discovered pathway in mammalian biology.
A surprising observation reported in this study was the rapid onset of dramatic premature aginglike phenotypes in Pum2 transgenic mice despite a lack of overt overexpression of PUM2 protein at the bulk tissue level. Given that production of transgenic FLAG-PUM2 is robustly detectable by IHC, the repression of endogenous PUMILIO through a previously described negative feedback mechanism 32-34 provides a likely explanation for the lack of increase in total PUM2 levels. This finding nonetheless raises the question of how transgene induction is able to drive such a striking phenotype if the protein product does not accumulate to supraphysiologic levels. An appealing hypothesis to explain this observation postulates that there are key vulnerable cell populations that become dysfunctional or damaged upon Pum2 induction. These cells may be rare or may naturally express lower levels of PUMILIO, such that a large change in PUM2 expression within them may be masked by the majority of cells in the tissue.
Alternatively, these cells may exhibit dynamic regulation of PUMILIO levels, for example as they transit the cell cycle, which is perturbed by heterologous Pum2 expression. Cells that are sensitive to enforced Pum2 expression likely include stem cell populations whose dysfunction could lead to loss of tissue homeostasis and degenerative phenotypes. Accordingly, PUMILIO and related proteins have been implicated as critical stem cell regulators in model organisms and mammals [37] [38] [39] [40] [41] [42] . Identification of cell populations that drive aging-associated phenotypes under conditions of Norad-deficiency or PUMILIO hyperactivity represents an important priority for future work as this approach may reveal new cell types whose dysfunction contributes to the natural aging-associated decline of tissue homeostasis and renewal.
Analyses of Norad-deficiency and enforced Pum2 expression unexpectedly revealed that PUMILIO hyperactivity triggers the coordinated repression of a large set of PUM2 target transcripts with key roles in mitochondrial function and homeostasis, associated with widespread structural and functional mitochondrial defects. A large body of evidence has linked a decline in mitochondrial function to aging-associated phenotypes 26 , including the direct demonstration that "mitochondrial mutator mice", which harbor a mutation in the mitochondrial DNA polymerase and consequently accumulate mtDNA mutations, develop a premature aging phenotype with many features in common with Norad -/mice 27 . Thus, mitochondrial dysfunction in concert with genomic instability, another abnormality associated with premature aging in mice 17,18 , provides a compelling mechanistic basis for the phenotype of Norad-deficient animals.
The regulation of mitochondrial biogenesis and function by PUMILIO-related proteins is not restricted to mammals. The budding yeast Puf family member Puf3p preferentially associates with mRNAs that encode mitochondrial proteins and facilitates their local translation in the vicinity of the mitochondrial protein import machinery [43] [44] [45] . In Drosophila and cultured mammalian cells, PUMILIO proteins repress translation of mRNAs that encode mitochondriadestined proteins until these transcripts are docked at the mitochondrial outer membrane 46 .
Together, these observations suggest a deeply conserved role for PUMILIO proteins in the regulation of mitochondrial biology across eukaryotic species.
Perhaps the most intriguing question to arise from these studies is whether dysregulation of the Norad-PUMILIO axis plays a role in physiologic aging and/or human disease. Remarkably, a recent RNA-seq study of noncoding RNA expression in the subependymal zone of human brains of increasing age reported a strong age-related decrease in NORAD expression 47 . These 13 findings take on added significance in light of our new understanding of the consequences of disruption of the Norad-PUMILIO axis and suggest that this lncRNA, and its target PUMILIO proteins, represent new candidates whose altered expression or function may influence the normal age-related decline in tissue function. These genes also represent previously unrecognized candidates that may be mutated or otherwise disrupted in rare progeroid cases that are unlinked to the genes that are presently known to cause these disorders. Thus, further study of the Norad-PUMILIO axis, and the pathways that regulate this noncoding RNA and its target proteins, promises to reveal important and unexpected new insights into mammalian physiology and disease.
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METHODS

Generation of mice with Norad deletion or enforced PUM2 expression
All animal protocols were approved by the Institutional Animal Care and Use Committee Founder mice harboring deletions of Norad were maintained by backcrossing to wild-type C57BL/6J mice. Of note, Norad -/lines were produced from three independent founder mice with Norad deletions (Supplementary Fig. 1c ). All were phenotypically indistinguishable and used for subsequent studies of Norad function. PUM1 and PUM2 overexpression clones using lentiviral transduction was described previously 5 .
Cell lines were tested and confirmed to be mycoplasma free.
RNA isolation and quantitative reverse transcription PCR (qRT-PCR)
Total RNA was isolated from cells or tissues using the miRNeasy Mini Kit (Qiagen) following the 
Enhanced UV crosslinking immunoprecipitation (eCLIP)
PUM2 RNA interactions in the mouse brain were determined by eCLIP, following a previously published protocol 19 All adapter sequences were removed using Cutadapt with an e-value set to 0.1. All reads less than 18 nt after adapter trimming were discarded, and the unique molecular identifiers (10 nt randomers) for PCR duplication identification were trimmed and recorded using in-house scripts. Because of the high number of NORAD pseudogenes in the human and mouse genome, we followed a similar mapping strategy to that used in our previous study 5 . Reads were first mapped to Norad (2900097C17Rik) before all remaining reads, which did not align to Norad, were mapped to GRCm38 (mm10) using Tophat2 (v2.0.12) with default settings 53 . Only uniquely mapped genomic reads were retained. PCR duplicates were then removed based on the unique molecular identifier information using in-house scripts. All remaining reads were regarded as usable reads and subjected to cluster calling. Table 2 ) and the Power SYBR Green PCR Master Mix (Applied Biosystems). The quantity of mtDNA was then normalized to the quantity of nDNA. Both mtDNA and nDNA concentrations were determined using standard curves. The number of replicates is provided in the respective figure legends.
Subcellular fractionation
Immortalized Norad +/+ MEFs were seeded in triplicate and harvested the next day for subcellular fractionation, which was performed as previously described 5 represented the nuclear soluble fraction, while the pellet yielded the chromatin fraction. All fractions were then subjected to RNA isolation and subsequent qRT-PCR. All samples were tested for Norad as well as for Neat1 (nuclear control) and Actb (cytoplasmic control).
Western blots
Cell and tissue lysates were prepared in RIPA buffer ( 
FLAG immunohistochemistry
Tissues were harvested from mice that had been treated with dox for 3.5-6.5 weeks. All tissues were fixed in 10% neutral buffered formalin (NBF) for 24-48 hours. Fixed samples were processed, paraffin embedded, and sectioned using standard procedures. To detect the expression of the FLAG-Pum2 transgene, immunohistochemistry (IHC) was performed by the UTSW Tissue Management Shared Resource using the monoclonal anti-FLAG M2 antibody (F1804, Sigma-Aldrich). Images were acquired on an AxioObserver Z1 microscope (Zeiss).
Histologic analysis of skeletal muscle and the central nervous system (CNS)
12-month-old Norad +/+ and Norad -/mice were used for semi-thin and ultrastructural analysis.
For these studies, one group of mice were given xylazine/ketamine anesthesia and euthanized by cardiac perfusion with 4% paraformaldehyde followed by 5% glutaraldehyde (both in 0.1 M phosphate buffer). Tissue samples from brain and spinal cord were removed under a dissecting microscope. A second group of mice were perfused with 4% paraformaldehyde and their muscles were removed and further fixed in situ in 5% glutaraldehyde. These tissues were dissected into small blocks and processed for plastic embedding using standard methods 60 .
Thick (1 µm) sections were stained with toluidine blue and selected blocks were sectioned and examined with an electron microscope (Hitachi H7650). Brain and spinal cord segments were placed in 10% NBF and processed for paraffin embedding. Brain, spinal cord, and skeletal muscle were collected from additional mice for cryostat sectioning. Muscle tissues from Pum2; rtTA3 as well as Pum2 and rtTA3 single transgenic littermates were collected and processed as for Norad -/mice. All transgenic mice were between 4 and 6 months old and had been treated with dox for 1.5-2 months.
To analyze neuronal cell loss in the ventral horn neuron pools, 5 µm thick, paraffin embedded and hematoxylin and eosin (H&E) stained lumbar spinal cord sections from Norad +/+ (n = 5) and and analyzed on an AxioObserver Z1 microscope (Zeiss) using the 100X oil objective.
Lymphocytes and splenocytes whose chromosome count differed from 2n for at least one of the two tested chromosomes were regarded as aneuploid or off mode. MEFs were only considered aneuploid when their chromosome count differed from 2n or a multiple of 2n in order to account for the increased polyploidy in this cell type.
Time-lapse microscopy
Primary Norad +/+ and Norad -/-MEFs (3 MEF lines per genotype, P<4) were grown on Lab-Tek Chambered Coverglass slides (Thermo Fisher) that were coated with poly-L-lysine (Sigma-Aldrich). Prior to the analysis, DNA was visualized by adding 50 ng/mL Hoechst dye (Invitrogen) to the growth medium. Mitoses were monitored by taking fluorescence images every 5 minutes for ~48 hours on a Leica inverted microscope equipped with a temperature and CO2-controlled chamber, a 63X oil objective, an Evolve 512 Delta EMCCD camera, and the MetaMorph Microscopy Automation and Image Analysis Software (Molecular Devices, LLC). Videos were generated from the acquired time-lapse images and analyzed for the occurrence of mitotic defects including anaphase bridges and lagging chromosomes.
Assessment of aging-associated phenotypes
Norad +/+ , Norad +/-, and Norad -/mice were continuously monitored over a period of 12 months for the onset and progression of kyphosis as well as alopecia and graying of fur. The kyphosis scoring system was adopted from a previously reported strategy 49 . In brief, a kyphosis score of 0 indicates no kyphosis detectable, a score of 1 indicates the presence of mild kyphosis but the mouse is still able to entirely stretch its spine, and scores of 2 and 3 indicate that there is prominent kyphosis at rest which persists in a mild (score of 2) or a severe (score of 3) form even when the mouse stretches its spine.
Analysis of whole-body fat and subcutaneous adipose tissue
Whole-body fat, as a percentage of body weight, was measured by nuclear magnetic resonance 
Quantification of mitochondrial membrane potential (MMP)
Tetramethylrhodamine ethyl ester (TMRE) (ENZ-52309, Enzo Life Sciences) was used for measuring mitochondrial membrane potential (MMP) in immortalized Norad +/+ and Norad -/-MEFs. 80 x 10 3 cells were seeded in triplicate in 6-well plates in regular growth medium and incubated for 16-18 hours until 70%-80% confluent. Cells were then trypsinized with 0.25% trypsin/EDTA (Gibco), pelleted at 300 g, and resuspended in 500 µL of fresh growth medium containing 50 nM TMRE. Samples were then incubated at 37°C in the dark for 30 minutes and analyzed by flow cytometry using a BD Accuri C6 Cytometer (BD Biosciences). The average and standard deviation of the mean fluorescence intensities of the 3 replicates was calculated for each sample, and each Norad -/-MEF line was compared to its Norad +/+ littermate control line.
Analysis of reactive oxygen species (ROS) and oxidative damage
The Enzo Total ROS Detection Kit (ENZ-51011, Enzo Life Sciences) was used for detection of ROS levels in immortalized MEFs and human HCT116 cells. 80 x 10 3 MEFs were plated in triplicate in 6-well plates in regular growth medium and incubated for 16-18 hours. 60 x 10 3 HCT116 cells were seeded in triplicate in 24-well plates in regular growth medium and also incubated for 16-18 hours. All cells were 70%-80% confluent at the time of the assay. ROS 
FLAG-PUM2 overexpression in MEFs
To overexpress PUM2 in MEFs, the same FLAG-Pum2 cDNA that was used for generating the transgenic mouse was cloned into a pBROAD3 vector (Invivogen), in which the Rosa26 promoter was replaced by a strong CAG promoter (pCAG-FLAG-Pum2). A pcDNA3-EGFP vector was used for control transfections. FLAG-PUM2 and EGFP were transfected into immortalized Norad +/+ MEFs using 2.5 µg of plasmid DNA and Lipofectamine 3000 (Invitrogen)
according to the manufacturer's protocol. In brief, 100 x 10 3 cells were seeded into 6-well plates and incubated overnight. The next day, cells were transfected with either pCAG-FLAG-Pum2 or pcDNA3-EGFP and incubated again overnight. The following day, cells were collected and replated for a second transfection, performed identically. After overnight incubation, cells were seeded for Seahorse analysis, as described above. PUM2 overexpression was assessed after the second transfection using western blot.
Statistical analysis
A comprehensive description of the RNA-seq and eCLIP analysis including the use of software is provided in the respective sections. The significance of the cumulative distribution functions was calculated using the Kolmogorov-Smirnov test and plotted in R. For all other analyses, statistical significance was analyzed using Prism 7 (GraphPad Software). Student's t tests or log-rank tests (for survival and phenotype incidence) were used to determine statistical significance, which is indicated as *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001. Data are presented as mean ± SD in all figures except Supplementary Fig. 5d, 8c (left graph) where the data are presented as mean ± SEM. The numbers of replicates are stated in the figure legends. log2 fold-change (KO / WT) p = 6.55x10 -14 p = 0.002 4 5 Cumulative fraction Supplementary Fig. 3 . Norad deficiency leads to genomic instability. a, Aneuploidy and polyploidy in primary MEFs. DNA FISH for two representative chromosomes (chr. 2 and 16) was performed to determine the frequency of diploid, polyploid, and aneuploid cells. Only cells with chromosome numbers differing from 2n or a multiple of 2n were regarded as aneuploid. 120 interphase nuclei per cell line were scored (n = 3 independent MEF lines per genotype). b, Rare polyploidy in lymphocytes and splenocytes from 12-month-old Norad -/mice. Additional data from the experiment in Fig. 4a is shown (12-month time-point). In only very rare cases (≤ 0.5%) were cells tetraploid for the two tested chromosomes. Data are represented as mean ± SD and p values were calculated using Student's t test. **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001. 
